Asia Oncology/Hematology Market Research Reports - Data on Oncology/Hematology in Asia page 1

Printer Format

Region:	All Regions > Asia
Category:	All Categories > Life Sciences > Pharmaceuticals > Therapeutic Area > Oncology/Hematology

(61 reports matching your criteria)

Lymphoma Treatment Drugs Markets in China 5/1/2013 \| published by: Asia Market Information & Development Company ... trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers ... \| read more...	$2,000.00
PharmaPoint: Chronic Myeloid Leukemia (CML) - Japan Drug Forecast and Market Analysis to 2022 4/30/2013 \| published by: GlobalData ... to 2022”. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the presence of the BCR-ABL fusion protein. The stage of CML is classified as chronic, accelerated or blast phase, ... \| read more...	$4,995.00
Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players 4/8/2013 \| published by: GBI Research ... its latest research, Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players, which provides in-depth analysis of the key therapeutic ... \| read more...	$3,500.00
PharmaPoint: Prostate Cancer - Japan Drug Forecast and Market Analysis to 2022 12/31/2012 \| published by: GlobalData ... of second-line metastatic castration-resistant prostate cancer (mCRPC) therapies like J&J’s Zytiga (abiraterone acetate) and Medivation/Astellas’ Xtandi (enzalutamide) will drive strong market growth over the next decade. These safe and orally administered treatments will provide safety ... \| read more...	$4,995.00
2013 Japanese Hospital Cancer Diagnostics Market 12/27/2012 \| published by: Venture Planning Group ... well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, ... \| read more...	$4,850.00
Forecast: Non-Small Cell Lung Cancer in China 12/12/2012 \| published by: Datamonitor ... and new therapies are launched in the Chinese market. Features and benefits Patient-based sales forecast for drugs in the Chinese NSCLC market from 2012 to 2021. In-depth analysis of the factors influencing the NSCLC market ... \| read more...	$11,400.00
Treatment: Non-Small Cell Lung Cancer in China 12/10/2012 \| published by: Datamonitor ... to gain insight into NSCLC diagnosis, patient segmentation, treatment patterns, and prescribing influences. Features and benefits Disease overview assessing etiology, risk factors, symptoms, and patient segmentation. In-depth analysis of most common treatment types according to ... \| read more...	$7,600.00
Chinese Markets for Cancer Treatment Drugs 10/1/2012 \| published by: Asia Market Information & Development Company ... trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers ... \| read more...	$2,000.00
Prostate Cancer in Russia 9/10/2012 \| published by: Decision Resources ... growth will be substantially higher than in the major markets. Changes in medical practice and a growing incident population offer significant opportunity to multinational companies (MNCs) with emerging therapies in this indication. In this report, ... \| read more...	$15,000.00
Chinese Markets for Cervical Cancer Treatment Drugs 9/1/2012 \| published by: Asia Market Information & Development Company ... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major ... \| read more...	$2,000.00
Chinese Markets for Skin Cancer Treatment Drugs 9/1/2012 \| published by: Asia Market Information & Development Company ... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major ... \| read more...	$2,000.00
China Oncology Prescription Drug Sales Data 2007-2011 9/1/2012 \| published by: Draco Healthcare Consulting LLC ... and drug purchasing data from extensive hospital coverage in 16 major cities and more than 300 hospitals. Sampled hospitals are from major Chinese cities across different geographic locations, including Beijing, Shanghai, Guangzhou, Nanjing, Chengdu, Chongqing, ... \| read more...	$8,000.00
Chinese Markets for Ovarian Cancer Treatment Drugs 9/1/2012 \| published by: Asia Market Information & Development Company ... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major ... \| read more...	$2,000.00
Chinese Markets for Brain Cancer Treatment Drugs 9/1/2012 \| published by: Asia Market Information & Development Company ... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major ... \| read more...	$2,000.00
Chinese Markets for Kidney Cancer Treatment Drugs 9/1/2012 \| published by: Asia Market Information & Development Company ... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major ... \| read more...	$2,000.00
Future Horizons in the Japanese Immunodiagnostics Market: Supplier Shares and Sales Forecasts for 100 Chemistry, TDM, Endocrine, Cancer, Immunoprotein and Abused Drug Tests by Market Segment 8/27/2012 \| published by: Venture Planning Group ... and technological trends with significant market impact during the next ten years. Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Japanese ... \| read more...	$6,800.00
Chinese Markets for Bladder Cancer Treatment Drugs 8/1/2012 \| published by: Asia Market Information & Development Company ... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major ... \| read more...	$2,000.00
Chinese Markets for Liver Cancer Treatment Drugs 8/1/2012 \| published by: Asia Market Information & Development Company ... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major ... \| read more...	$2,000.00
Chinese Markets for Lung Cancer Treatment Drugs 8/1/2012 \| published by: Asia Market Information & Development Company ... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major ... \| read more...	$2,000.00
Chinese Markets for Breast Cancer Treatment Drugs 8/1/2012 \| published by: Asia Market Information & Development Company ... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major ... \| read more...	$2,000.00
Chinese Markets for Prostate Cancer Treatment Drugs 8/1/2012 \| published by: Asia Market Information & Development Company ... economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major ... \| read more...	$2,000.00
Non-Small-Cell Lung Cancer in China 7/16/2012 \| published by: Decision Resources ... and a burgeoning middle class with growing economic clout, these factors promise double-digit growth and significant opportunity for multinational pharmaceutical companies. Please note, the PDF e-mail from publisher version of this report is for a ... \| read more...	$15,000.00
Colorectal Cancer in Russia 5/17/2012 \| published by: Decision Resources ... practice and a growing incident population offer significant opportunity to multinational companies (MNCs) with emerging therapies in this indication. In this report, we examine the trends within Russia’s CRC therapy market, which is characterized by ... \| read more...	$15,000.00
2012 Japan Tumor Marker Testing Market Outlook: Growth Opportunities and Strategies 4/24/2012 \| published by: Venture Planning Group ... during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ... \| read more...	$6,700.00
Anti-cancer Drugs Market in Japan 2011-2015 4/5/2012 \| published by: Infiniti Research Limited ... the number of cancer patients in the country. The Anti-cancer Drugs market in Japan has also been witnessing the trend of using a combination of cancer therapies for treatment. However, stringent government regulations in Japan ... \| read more...	$1,500.00

< prev 1 2 3 next >